BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8653938)

  • 1. Pharmacologic prevention of colonic neoplasms. Effects of calcium, vitamins, omega fatty acids, and nonsteroidal anti-inflammatory drugs.
    Eastwood GL
    Dig Dis; 1996; 14(2):119-28. PubMed ID: 8653938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of gastrointestinal epithelial renewal and its relevance to the development of adenocarcinomas of the gastrointestinal tract.
    Eastwood GL
    J Clin Gastroenterol; 1995; 21 Suppl 1():S1-11. PubMed ID: 8774983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV; Hirose Y; Indranie C; Reddy BS
    Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion.
    Reddy BS; Simi B; Patel N; Aliaga C; Rao CV
    Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats.
    Rao CV; Simi B; Wynn TT; Garr K; Reddy BS
    Cancer Res; 1996 Feb; 56(3):532-7. PubMed ID: 8564967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats.
    Reddy BS; Sugie S
    Cancer Res; 1988 Dec; 48(23):6642-7. PubMed ID: 3180073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
    Reddy BS
    Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer.
    Turner D; Berkel HJ
    CMAJ; 1993 Sep; 149(5):595-602. PubMed ID: 8364816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of carcinogenesis in familial tumors.
    Ishikawa H
    Int J Clin Oncol; 2004 Aug; 9(4):299-303. PubMed ID: 15375706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional-pharmacological combinations--a novel approach to reducing colon cancer incidence.
    Schwartz B; Birk Y; Raz A; Madar Z
    Eur J Nutr; 2004 Aug; 43(4):221-9. PubMed ID: 15309441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
    Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.
    Luk GD
    Schweiz Med Wochenschr; 1996 May; 126(19):801-12. PubMed ID: 8693304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon cancer prevention. Worth the trouble.
    Harv Health Lett; 1999 Nov; 25(1):1-2. PubMed ID: 10521900
    [No Abstract]   [Full Text] [Related]  

  • 17. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
    Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
    Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
    Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. n-3 PUFA and alpha-tocopherol control of tumor cell proliferation.
    Bartoli GM; Palozza P; Marra G; Armelao F; Franceschelli P; Luberto C; Sgarlata E; Piccioni E; Anti M
    Mol Aspects Med; 1993; 14(3):247-52. PubMed ID: 8264339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
    Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
    Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.